Prevail Innovative Wealth Advisors »

Cue Biopharma shares owned by Prevail Innovative Wealth Advisors

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Prevail Innovative Wealth Advisors from 13F filings

Historical chart of Prevail Innovative Wealth Advisors investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Prevail Innovative Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Prevail Innovative Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.8k 19k 0.31
2025-09-30 $14k 19k 0.72
2025-06-30 $13k 19k 0.68

More positions owned by Prevail Innovative Wealth Advisors

Franklin Templeton Etf Tr Senior Loan Etf (FLBL)
Ssga Active Etf Tr State Street Bla (SRLN)
Ishares Tr 20+ Year Tr Bd (TLTW)
American Centy Etf Tr Avantis Us Small (AVSC)
Exxon Mobil Corporation (XOM)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange Traded F Hedged Equity La (HELO)
Neos Etf Trust Neos S&p 500 Hi (SPYI)
Vertex Pharmaceuticals Incorporated (VRTX)
Global X Fds Defense Tech Etf (SHLD)
Meta Platforms Cl A (META)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Prevail Innovative Wealth Advisors

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Lion Point Capital
Geode Capital Management
Boothbay Fund Management
Robertson Stephens Wealth Management
BlackRock
Texas Capital Bank Wealth Management Services
Advisory Research
Stifel Financial
Renaissance Technologies
State Street Corporation
Susquehanna International
Angeles Wealth Management

View all funds holding Cue Biopharma